UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000010576 |
|---|---|
| Receipt number | R000012361 |
| Scientific Title | Immunogenicity and safety of 4 doses compared to 3 doses of 13-valent pneumococcal conjugate vaccine in allogeneic hematopoietic stem cell transplantation recipients |
| Date of disclosure of the study information | 2013/04/23 |
| Last modified on | 2022/12/09 15:07:31 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/04/23 20:31:07 | ||
| 2 | Update | 2013/10/26 06:58:27 | Email |
|
| 3 | Update | 2013/11/26 14:01:14 | Email1 |
|
| 4 | Update | 2015/04/23 10:34:24 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key inclusion criteria Key inclusion criteria |
|
| 5 | Update | 2016/05/02 02:34:46 | Name of primary person or sponsor Organization Organization Category of Funding Organization |
|
| 6 | Update | 2017/10/26 22:57:11 | Recruitment status |
|
| 7 | Update | 2018/10/28 02:23:25 | Last follow-up date |
|
| 8 | Update | 2019/04/30 07:56:23 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 9 | Update | 2019/11/01 01:50:49 | Date of IRB Date of closure to data entry Date trial data considered complete |
|
| 10 | Update | 2022/12/09 15:05:41 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 11 | Update | 2022/12/09 15:07:07 | Recruitment status |
|
| 12 | Update | 2022/12/09 15:07:31 | Publication of results |
